Literature DB >> 27255703

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice.

Molly Foote1, Gloria Arque2, Robert F Berman3, Mónica Santos4.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that affects some carriers of the fragile X premutation (PM). In PM carriers, there is a moderate expansion of a CGG trinucleotide sequence (55-200 repeats) in the fragile X gene (FMR1) leading to increased FMR1 mRNA and small to moderate decreases in the fragile X mental retardation protein (FMRP) expression. The key symptoms of FXTAS include cerebellar gait ataxia, kinetic tremor, sensorimotor deficits, neuropsychiatric changes, and dementia. While the specific trigger(s) that causes PM carriers to progress to FXTAS pathogenesis remains elusive, the use of animal models has shed light on the underlying neurobiology of the altered pathways involved in disease development. In this review, we examine the current use of mouse models to study PM and FXTAS, focusing on recent advances in the field. Specifically, we will discuss the construct, face, and predictive validities of these PM mouse models, the insights into the underlying disease mechanisms, and potential treatments.

Entities:  

Keywords:  CGG trinucleotide repeat; Fragile X mental retardation (FMR1) gene; Fragile X premutation; Fragile X-associated tremor/ataxia syndrome (FXTAS); Mouse models; Neurodegenerative disorder

Mesh:

Year:  2016        PMID: 27255703      PMCID: PMC5014696          DOI: 10.1007/s12311-016-0797-6

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  73 in total

1.  Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?

Authors:  S L Sherman
Journal:  Am J Hum Genet       Date:  2000-06-12       Impact factor: 11.025

Review 2.  FMR1 and the continuum of primary ovarian insufficiency.

Authors:  Shannon D Sullivan; Corrine Welt; Stephanie Sherman
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

3.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

4.  Fragile X-associated tremor/ataxia syndrome: An under-recognised cause of tremor and ataxia.

Authors:  Sarah Kalus; John King; Elaine Lui; Frank Gaillard
Journal:  J Clin Neurosci       Date:  2015-10-02       Impact factor: 1.961

5.  Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study.

Authors:  Cary S Kogan; Jeremy Turk; Randi J Hagerman; Kim M Cornish
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

Review 6.  Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome.

Authors:  Claudine M Kraan; Darren R Hocking; John L Bradshaw; Joanne Fielding; Jonathan Cohen; Nellie Georgiou-Karistianis; Kim M Cornish
Journal:  Neurosci Biobehav Rev       Date:  2013-01-23       Impact factor: 8.989

Review 7.  Prevalence of FMR1 repeat expansions in movement disorders. A systematic review.

Authors:  D A Hall; R J Hagerman; P J Hagerman; S Jacquemont; M A Leehey
Journal:  Neuroepidemiology       Date:  2006-02-21       Impact factor: 3.282

8.  Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model.

Authors:  Ali Entezam; Rea Biacsi; Bonnie Orrison; Tapas Saha; Gloria E Hoffman; Ed Grabczyk; Robert L Nussbaum; Karen Usdin
Journal:  Gene       Date:  2007-03-16       Impact factor: 3.688

9.  Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers.

Authors:  Claudine M Kraan; Darren R Hocking; Nellie Georgiou-Karistianis; Sylvia A Metcalfe; Alison D Archibald; Joanne Fielding; Julian Trollor; John L Bradshaw; Jonathan Cohen; Kim M Cornish
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-10-26       Impact factor: 3.568

Review 10.  Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Authors:  Randi J Hagerman; Deborah A Hall; Sarah Coffey; Maureen Leehey; James Bourgeois; John Gould; Lin Zhang; Andreea Seritan; Elizabeth Berry-Kravis; John Olichney; Joshua W Miller; Amy L Fong; Randall Carpenter; Cathy Bodine; Louise W Gane; Edgar Rainin; Hillary Hagerman; Paul J Hagerman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  5 in total

Review 1.  General Anesthetic Use in Fragile X Spectrum Disorders.

Authors:  Andrew Ligsay; Marwa El-Deeb; Maria J Salcedo-Arellano; Nina Schloemerkemper; Jeremy S Grayson; Randi Hagerman
Journal:  J Neurosurg Anesthesiol       Date:  2019-07       Impact factor: 3.956

2.  Selective rescue of heightened anxiety but not gait ataxia in a premutation 90CGG mouse model of Fragile X-associated tremor/ataxia syndrome.

Authors:  Hoanna Castro; Emre Kul; Ronald A M Buijsen; Lies-Anne W F M Severijnen; Rob Willemsen; Renate K Hukema; Oliver Stork; Mónica Santos
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

Review 3.  RNA toxicity and foci formation in microsatellite expansion diseases.

Authors:  Nan Zhang; Tetsuo Ashizawa
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

4.  341 Repeats Is Not Enough for Methylation in a New Fragile X Mouse Model.

Authors:  Steven Colvin; Nick Lea; Qiangge Zhang; Martin Wienisch; Tobias Kaiser; Tomomi Aida; Guoping Feng
Journal:  eNeuro       Date:  2022-09-12

Review 5.  Intellectual disability: dendritic anomalies and emerging genetic perspectives.

Authors:  Tam T Quach; Harrison J Stratton; Rajesh Khanna; Pappachan E Kolattukudy; Jérome Honnorat; Kathrin Meyer; Anne-Marie Duchemin
Journal:  Acta Neuropathol       Date:  2020-11-23       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.